Laboratoires Pierre Fabre

Laboratoires Pierre Fabre have taken an important step forward in the fight against metastatic colorectal cancer. We are proud to announce that we submitted a new application to the European Medicines Agency (EMA) to extend the current marketing authorization of one of our oncology treatments for adults with BRAFV600E-mutant metastatic colorectal cancer, a particularly aggressive form of the disease. This submission is supported by positive results from a phase 3 clinical trial. 🤝 This milestone follows an update to our agreement with Array BioPharma Inc., a subsidiary of Pfizer., granting Pierre Fabre the rights to the study data. This access enables the company to pursue regulatory submissions in its licensed territories and further its mission to expand access to innovative oncology treatments. With over 40 years of expertise in oncology, we continue to advance cancer care by investing in targeted therapies and collaborative research that address unmet medical needs 🔬 

Les Laboratoires Pierre Fabre sont ravis d'annoncer leur partenariat avec Jinko pour lancer un programme d'accompagnement innovant. 🤝 Ensemble, nous visons à transformer la qualité de vie des patients en oncologie en intégrant des soins de support essentiels dans leur parcours de santé. 💡Notre approche ? Offrir aux patients un espace dédié à leur bien-être, en complément de leur suivi médical, en mettant l'accent sur la nutrition, la gestion des douleurs, et la santé mentale. Les éléments clés de ce programme, destiné aux patients atteints de cancer colorectal, incluent : 👉 Une infirmière de coordination pour un accompagnement personnalisé. 👉 Un parcours de soins de support sur mesure. 👉 Une application digitale sécurisée avec des contenus validés par des experts de santé. Ce programme représente un soutien indispensable pour les patients et un appui précieux pour les équipes médicales. Nous sommes fiers de cette collaboration avec Jinko et déterminés à continuer d'innover pour le bien-être des patients atteints de cancer. Ensemble, nous faisons la différence dans le quotidien des patients.   #PierreFabre #NewWaysToCare #innovation #oncologie

Laboratoires Pierre Fabre are participating in the ESMO Congress 2025 in Berlin from October 17-21, 2025, at Booth #1012 Hall 1.2. The ESMO - European Society for Medical Oncology is a leading organization dedicated to advancing medical oncology and cancer research. As a leader in oncology, Pierre Fabre will join more than 33,000 doctors from 149 countries to exchange insights on the latest oncology innovations and share new data that can shape the future of cancer treatment. Our presence at this influential global event underscores our dedication to improving patient outcomes and fostering partnerships that drive progress in oncology. 👉 Stay connected with us on Pierre Fabre Oncology for more updates ! #PierreFabre #NewWaysToCare #ESMO25 # Oncology #Innovation

Ruscus embodies the spirit of collective entrepreneurship at Pierre Fabre Laboratories, symbolising trust, commitment and pride within our company. 🎬 In this last video in our series, Maud Vimeux, Director of Human Resources, and Nicolas Villet, Managing Director of BNP Paribas Épargne Retraite et Entreprise, share their thoughts on what makes Ruscus unique:  👉 Employee share ownership as a lever for commitment, strengthening the bond between employees and the company and creating a united social body.  👉 The significant contribution of employee share ownership to value creation, by building loyalty and commitment within our community.  👉 The crucial role of Ruscus facilitators, whose commitment has been fundamental in conveying the spirit of this collective adventure. At Pierre Fabre Laboratories, being a shareholder means being a key player in our performance, our growth and our shared impact. Watch the last episode of the series right here 👇 #3

Did you know there are more than 12 potential different signs of breast cancer? It’s not just about finding a lump. Look for changes in shape, skin texture, or even unusual itchiness. Learn all the signs, not just one. Early detection starts with awareness! Be sure to ask your healthcare professional about any questions or concerns you may have Knowledge is power—let’s #KnowYourLemons together! #PierreFabre #NewWaysToCare #BreastAwarenessMonth #BreastCancer

🌍 Today, we celebrate European Donation Day, the European Day for Organ, Tissue and Cell Donation, and thank donors and their families. Their generosity has transformed lives through transplantation, offering the gift of hope to thousands of people across the region. On this day, it’s also important to acknowledge that some transplant recipients may continue to face complex health challenges even after a successful transplant. This could include PostTransplant Lymphoproliferative Disorder (PTLD) – a rare and serious condition that can occur after both solid organ and haematopoietic stem cell transplants. Diagnosing PTLD can be difficult. It often mimics other post-transplant complications, such as infections or organ rejection, leading to potential delays in treatment. Timely and accurate diagnosis can be achieved using tools like tissue biopsy, imaging and EBV monitoring. At Pierre Fabre, we are dedicated to supporting the transplant community, from donor to recipient, by helping raise awareness of conditions like PTLD and advocating for early diagnosis. This European Donation Day, share the importance of organ, tissue and cell donation and help shine a light on the challenges faced after transplantation. To find out more, visit www.ptld.eu #EDD25 #PTLD #ABrightJourney #TakingCareLivingBetter #PierreFabre #WeArePierreFabre

For 20 years, Ruscus has embodied the spirit of collective entrepreneurship at Pierre Fabre. More than just an employee shareholding plan, it’s a symbol of trust, engagement, and independence. 🎬 In this new video capsule, Pierre-Yves Revol, President of the Fondation Pierre Fabre and Eric Ducournau, CEO of Laboratoires Pierre Fabre, reflect on what makes Ruscus truly unique: 👉 The legacy of Pierre Fabre, who bequeathed his company to a Foundation, an act of generosity and vision ensuring its long-term independence. 👉 The remarkable commitment of Ruscus ambassadors, who helped colleagues embrace this collective journey. 👉 And the power of having over 80% of employees as shareholders across 14 countries, creating motivation, shared purpose, and accountability. At Pierre Fabre, being a shareholder means being an actor in our shared performance, growth, and impact. Discover their words in our #2 capsule 👇

At Laboratoires Pierre Fabre, we believe that every success is a collective one. Twenty years ago, our founder Pierre Fabre launched Ruscus, our employee shareholding plan, inviting employees to become future entrepreneurs of the company. Two decades later, his vision lives on: 80% of our employees are shareholders across 14 countries, making them the second largest shareholder of the company, alongside the Fondation Pierre Fabre . As we celebrate this 20-year milestone, we are proud to look back at how Ruscus has strengthened engagement, trust, and a shared sense of purpose within our teams worldwide. 🎬 To mark the occasion, we invited Patrick Martinn, President of Mouvement des Entreprises de France, and Jean Claude Mailly, former Secretary General of Force Ouvrière, to share their insights on the importance of employee ownership and collective value creation. Watch the first episode of our series 👇

What’s really inside your breast? Understanding breast anatomy helps you spot changes early. Each breast is made up of fat, glands, ducts, and connective tissue—making everyone’s breast unique. Knowing your lemons means knowing your body, so you can notice when something feels different. Stay tuned as we explore the signs you shouldn’t ignore. Knowledge is power—let’s #KnowYourLemons together! #PierreFabre #NewWaysToCare #BreastAwarenessMonth #BreastCancer

This October let’s talk openly about breast cancer awareness. Pierre Fabre Laboratoires is joining forces with Know Your Lemons to empower people everywhere with knowledge, early detection tools, and hope. Throughout this campaign, we’ll share essential information about breast health, the signs to watch for, and the steps you can take to protect yourself and your loved ones. For more details, visit the Pierre Fabre website: https://lnkd.in/eZNSybH7 Knowledge is power—let’s #KnowYourLemons together! #PierreFabre #NewWaysToCare #BreastAwarenessMonth #BreastCancer